CD274 and neoplasm: It has been shown that the nucleoside analog 6-thio-dG leads to tumor regression through innate and adaptive immune-stimulatory responses and overcomes resistance to checkpoint inhibitors (PD-L1/PD-1blockade resistance) in mouse models.